REC — Recordati Industria Chimica e Farmaceutica Share News
0.000.00%
Last trade - 00:00- €10.91bn
- €12.82bn
- €2.62bn
Recordati says 2025 profit to be hit by weak economy, currency impact
Italy - Factors to watch on November 12
Brief: Recordati 9M Adjusted Net Income EUR 493.1 Million
Brief: Recordati Says Business Expected To Deliver FY 2025 Results In Line With Original Guidance (Lower Half Of Range)
Brief: Recordati 9M Revenue EUR 1,956.2 Million
Italy - Factors to watch on November 11
Brief: Recordati - Appoints Mike McClellan CFO
Italy - Factors to watch on September 25
Italy - Factors to watch on Sept. 19
Brief: Recordati Says CFO Luigi La Corte Resigns
Top of the Street: NN Group, Symrise, Metso, Recordati
Jefferies ups Recordati to 'buy' on rare disease momentum, M&A upside
Italy's Recordati CEO sees rare disease drugs exempt from U.S. tariffs
Brief: There will be 15% U.S. tariffs on pharma, exemption for rare diseases, Recordati CEO says
Italy - Factors to watch on July 30
Recordati's core profit rises, but sees bigger FX hit
Brief: Recordati H1 EBITDA EUR 496.3 Million
Brief: Recordati H1 Revenue EUR 1,323.8 Million
Brief: Recordati H1 EBITDA EUR 496.3 Mln